PDT Partners LLC acquired a new stake in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 91,315 shares of the company’s stock, valued at approximately $867,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. RiverPark Advisors LLC purchased a new position in shares of Enfusion in the 2nd quarter worth approximately $68,000. Arizona State Retirement System purchased a new position in Enfusion in the second quarter worth $86,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Enfusion during the first quarter worth $102,000. Harbor Capital Advisors Inc. lifted its holdings in shares of Enfusion by 12.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after purchasing an additional 1,315 shares during the last quarter. Finally, Belvedere Trading LLC acquired a new stake in shares of Enfusion in the 3rd quarter worth $114,000. Hedge funds and other institutional investors own 81.05% of the company’s stock.
Enfusion Price Performance
Shares of NYSE:ENFN opened at $10.14 on Tuesday. The business’s 50-day moving average is $9.33 and its 200 day moving average is $8.89. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.40. The firm has a market capitalization of $1.30 billion, a P/E ratio of 253.50, a P/E/G ratio of 3.72 and a beta of 0.93.
About Enfusion
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
See Also
- Five stocks we like better than Enfusion
- Insider Trades May Not Tell You What You Think
- How to Master Trading Discipline: Overcome Emotional Challenges
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Market Cap Calculator: How to Calculate Market Cap
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.